In cyclic-AMP accumulation assays, semaglutide displayed full agonism with an EC 50 in the low-nanomolar range, and -arrestin recruitment indicated balanced downstream signaling
In these individuals it would appear that whilst they were able to exist as relatively healthy individuals, often not knowing that they had methylation associated mutations, some initiating factor such as a prolonged infection, combined with low vitamin D levels resulted in gradual loss of their vitamin B12 supplies leading to the CFS symptomatology being apparent, and the subsequent discovery of their methylation status
doi:.10.3945/ajcn.2008.27416 [PMC free article: PMC2762159] [PubMed: 19759171] [CrossRef] 314
So someone whos already fairly thin and is taking semaglutide could possibly become underweight or lose relevant amounts of muscle, though Klein notes that he hasnt seen any case reports of this happening yet
The new hair pushes through
PubMed 31611038 Wikipedia